Pfizer (NYSE: PFE) and Teva Pharmaceutical Industries (NYSE: TEVA) just reported third-quarter earnings that reveal two ...

Neurocrine Biosciences stock, part of the high-ranking biotech industry group, is trading back inside a buy zone.

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 9:30 AM ESTCompany ParticipantsMatthew Abernethy ...

National analyses reveal widespread psychotropic prescribing to infants, toddlers, and young children. CCHR is urging ...

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing ...

Terrell Davis, TD, has been a mental health advocate ever since going public about his own mental health challenges. That's ...

Neurocrine Biosciences (NBIX) recently caught attention with the publication of a comprehensive peer-reviewed review that brings together more than ten years of research on its VMAT2 inhibitors for ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

Calling him a “tremendous” health advocate, DeMyers adds that leveraging Davis to get the word out about TD will help more people start conversations with their doctors about the condition. Going ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of a comprehensive peer-reviewed narrative review that consolidates pharmacologic, pharmacokinetic and more than a decade of ...

As with other drugs, Latuda (lurasidone) can cause side effects, such as restlessness, nausea, and weight gain. If side effects of Latuda become difficult to tolerate, talk with your doctor or ...